| Medgenics files IND application with US FDA for Epodure Biopump phase IIb ... - pharmabiz.com |
|
|
pharmabiz.com Positive data from the company's phase I/II dose-ranging study of Epodure in pre-dialysis patients were presented at the 2010 and the 2011 American Society of Nephrology Annual Meetings, and demonstrated that a single administration can raise and |